EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Albumin-Binding Domains in Therapeutic Protein Engineering: A Structural and Computational Perspective on Rational Design

Matthew J Argyle, Dallin M Chipman, Anna Claire Woolley, Bradley C Bundy, Dennis Della Corte

SynBio · 12.02.2026 · 4 (1) · 5

DOI: 10.3390/synbio4010005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SynBio, online erschienen am 12.02.2026. Verfasst von Matthew J Argyle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics and Astronomy, Brigham Young University, Utah. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic proteins face a critical pharmacokinetic challenge: rapid clearance from circulation limits their clinical efficacy. Albumin-binding domains (ABDs) offer an elegant solution by enabling therapeutic proteins to “hitchhike” on serum albumin’s favorable 19-day half-life through FcRn-mediated recycling. Clinical validation through approved therapeutics like ozoralizumab demonstrates the success of this approach, with preclinical studies showing fusion to an ABD extended half-life to 18 days. This review provides an analysis of ABD-fusion protein design, integrating structural biology, computational prediction, and rational engineering principles. We catalog the major classes of albumin-binding modalities, including bacterial three-helix bundle domains, engineered peptides, antibody-derived binders, and alternative scaffolds, comparing their binding properties, size contributions, cross-species reactivity, and production cost. Critical examination of linker architectures reveals that flexible glycine-serine linkers (particularly the widely successful (GGGGS)3 motif) provide optimal balance between domain independence and molecular economy, though linker choice profoundly influences not only spatial separation but also binding affinity, folding, stability, and pharmacokinetics. We evaluate the utility and limitations of the structure prediction tools for ABD-fusion design. We establish practical guidelines for integrating computational screening with experimental validation. This review provides protein engineers and synthetic biologists with a comprehensive framework for rational design of albumin-binding therapeutics, emphasizing the synergistic integration of structural insight, computational prediction, and systematic experimental validation to accelerate development of next-generation long-acting biotherapeutics.

Schlagwörter

Stichwörter der Autor:innen

AlphaFoldFcRn recyclingalbumin-binding domainhalf-life extensionlinker designprotein fusionstructure predictiontherapeutic protein engineering

Autor:innen und Institutionen

  • Department of Physics and Astronomy, Brigham Young University, Utah.
  • Department of Chemical and Biological Engineering, Brigham Young University, Utah.

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences of the National Institutes of Health

Zitieren

APA

Argyle, M. J., Chipman, D. M., Woolley, A. C., Bundy, B. C., & Della Corte, D. (2026). Albumin-Binding Domains in Therapeutic Protein Engineering: A Structural and Computational Perspective on Rational Design. SynBio, 4(1), 5. https://doi.org/10.3390/synbio4010005

Vancouver

Argyle MJ, Chipman DM, Woolley AC, Bundy BC, Della Corte D. Albumin-Binding Domains in Therapeutic Protein Engineering: A Structural and Computational Perspective on Rational Design. SynBio. 2026;4(1):5. doi:10.3390/synbio4010005

BibTeX
@article{Argyle2026,
  author = {Argyle, Matthew J and Chipman, Dallin M and Woolley, Anna Claire and Bundy, Bradley C and Della Corte, Dennis},
  title = {Albumin-Binding Domains in Therapeutic Protein Engineering: A Structural and Computational Perspective on Rational Design},
  journal = {SynBio},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {5},
  doi = {10.3390/synbio4010005}
}
Kostenlos starten →